NCT07392957: Safety and Efficacy of CTX-009 With or Without CTX-471 for Recurrent Glioblastoma
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 54 planned
- Started
- 16 Jun 2026
- Primary completion
- 30 Jun 2029
- Arms
- Phase IB Arm 2: CTX-009 and CTX-471 combination therapy, Phase II Expansion Arm 2: CTX-009 and CTX-471 combination therapy
- Results
- None posted
- 6 Feb 2026: Trial registered
- 16 Jun 2026: Trial started